Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication
NCT ID: NCT01415024
Last Updated: 2011-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
30 participants
INTERVENTIONAL
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the "CRT ICD Dual LV" study the patients receive a second LV lead in an anterior vein. When this lead is placed, temporary dual LV stimulation is started. To assess the effectivity of the dual LV lead stimulation intraoperatively a LV dp/dt-pressure measurement is taken. If there is an increase in LV dp/dt, the patients will be stimulated with both leads permanently. If not they will be stimulated conventionally.
The patients participating in this study are monitored for 12 months after implantation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders
NCT05760924
Combining Myocardial Strain and Cardiac CT to Optimize Left Ventricular Lead Placement in CRT Treatment
NCT01426321
TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study
NCT00746135
Safety and Performance Aspects of CRT-DX System in Patients With Sinus Rhythm
NCT03839121
Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
NCT00833352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
second LV lead in CRT
second LV lead in CRT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CAD or dilatative Cardiomyopathy
* Sinus rhythm
* NYHA III or IV, stable recompensated
* QRS more than 120ms
* LBBB
* Patient signed Consent Form
* Age more than 18 and less than 80 y
Exclusion Criteria
* permanent AV-Block II or III
* Tricuspidal- and or artificial aortic valve
* Indication for ACB or ACB less than 3 months ago
* myocardial infarction less than 3 months
* hypertrophic obstructive Cardiomyopathy; constrictive Pericarditis
* heartfailure with iv catecholamine therapy
* Manifested, uncontrolled, Hypo- oder Hyperthyreosis
* Severe renal insufficiency with Creatinine more than 2,5 mg per dL
* patients, who did not sign the consent form
* General medical conditions, which restrict the patient compliance
* Participation in another study
* life expectancy less than 1 y
* Age less than 18 y or more than 80y
* Pregnant women or Women of childbearing age
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Schuechtermann-Klinik
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Schuechtermann- Klinik
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Kranig, MD
Role: PRINCIPAL_INVESTIGATOR
Schuechtermann-Klinik
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schuechtermann-Klinik
Bad Rothenfelde, Lower Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BO/01/2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.